Fmr Llc, See Remark 1 at Blueprint Medicines, holds 4.01M shares in Beam Therapeutics (Ticker: BEAM), holds 7.54M shares in Neumora Therapeutics, Inc. (Ticker: NMRA), holds 1.13M shares in Turnstone Biologics Corp. (Ticker: TSBX). Most recently, Fmr Llc Sold ― shares of Beam Therapeutics on Feb 15, 2024 for an estimated value of 27.55M.
Fmr Llc latest transaction was an Informative Sell of $27.55M.
What was Fmr Llc's most profitable transaction?
Fmr Llc’s most profitable transaction was an Informative Buy of VRAYQ stock on March 30, 2016. The return on the trade was 104.30%.
What is Fmr Llc's role in Blueprint Medicines?
Fmr Llc's role in Blueprint Medicines is See Remark 1.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.